Agios Pharmaceuticals (AGIO) Other Gross PP&E Adjustments (2016 - 2025)
Agios Pharmaceuticals (AGIO) has disclosed Other Gross PP&E Adjustments for 13 consecutive years, with $22.1 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 424.74% year-over-year to $22.1 million, compared with a TTM value of $22.1 million through Dec 2025, up 424.74%, and an annual FY2025 reading of $22.1 million, up 424.74% over the prior year.
- Other Gross PP&E Adjustments was $22.1 million for Q4 2025 at Agios Pharmaceuticals, up from -$33.6 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $22.1 million in Q4 2025 and bottomed at -$79.9 million in Q2 2021.
- Average Other Gross PP&E Adjustments over 5 years is -$36.2 million, with a median of -$39.9 million recorded in 2025.
- The sharpest move saw Other Gross PP&E Adjustments tumbled 14379.68% in 2022, then surged 424.74% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at -$28.4 million in 2021, then surged by 35.63% to -$18.3 million in 2022, then skyrocketed by 57.66% to -$7.8 million in 2023, then soared by 154.22% to $4.2 million in 2024, then soared by 424.74% to $22.1 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for AGIO at $22.1 million in Q4 2025, -$33.6 million in Q3 2025, and -$36.8 million in Q2 2025.